2022 Q1 Form 10-Q Financial Statement

#000190163722000004 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $15.34M $13.73M
YoY Change 11.76%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $387.0K $508.0K
YoY Change -23.82%
% of Gross Profit
Depreciation & Amortization $188.0K $190.0K $330.0K
YoY Change -43.03% -40.63% 6.45%
% of Gross Profit
Operating Expenses $387.0K $508.0K
YoY Change -23.82%
Operating Profit
YoY Change
Interest Expense $963.0K $1.253M
YoY Change -23.14%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $6.712M $7.400M $6.279M
YoY Change 6.9% 57.78% 173.0%
Income Tax $1.858M $1.750M $1.498M
% Of Pretax Income 27.68% 23.65% 23.86%
Net Earnings $4.854M $5.650M $4.781M
YoY Change 1.53% 33.25% 174.77%
Net Earnings / Revenue 31.64% 34.83%
Basic Earnings Per Share
Diluted Earnings Per Share $241.4K $1.066M $239.1K
COMMON SHARES
Basic Shares Outstanding 20.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $94.11M $46.23M $105.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $18.69M $5.278M $20.00M
YoY Change -6.57% -16.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.86M $34.90M $39.20M
YoY Change -0.87% -10.97%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.967B $1.854B $1.633B
YoY Change 20.44% 23.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $23.64M $22.20M $21.70M
YoY Change 8.95% 6.73%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.64M $22.20M $21.70M
YoY Change 8.95% 6.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.277M $1.400M $1.000M
YoY Change 127.7% 180.0%
Total Long-Term Liabilities $2.277M $1.400M $1.000M
YoY Change 127.7% 180.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.64M $22.20M $21.70M
Total Long-Term Liabilities $2.277M $1.400M $1.000M
Total Liabilities $1.775B $1.650B $1.463B
YoY Change 21.35% 23.99%
SHAREHOLDERS EQUITY
Retained Earnings -$119.4M -$124.2M
YoY Change 131.71%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $192.0M $203.9M $170.4M
YoY Change
Total Liabilities & Shareholders Equity $1.967B $1.854B $1.633B
YoY Change 20.44% 23.45%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income $4.854M $5.650M $4.781M
YoY Change 1.53% 33.25% 174.77%
Depreciation, Depletion And Amortization $188.0K $190.0K $330.0K
YoY Change -43.03% -40.63% 6.45%
Cash From Operating Activities $5.603M -$1.600M $4.059M
YoY Change 38.04% 14.29% 479.86%
INVESTING ACTIVITIES
Capital Expenditures $155.0K -$320.0K $184.0K
YoY Change -15.76% 300.0% -304.44%
Acquisitions
YoY Change
Other Investing Activities -$80.58M -$127.1M -$75.72M
YoY Change 6.42% -11.24% -320.76%
Cash From Investing Activities -$80.74M -$127.4M -$75.90M
YoY Change 6.37% -11.07% -321.87%
FINANCING ACTIVITIES
Cash Dividend Paid $781.0K
YoY Change
Common Stock Issuance & Retirement, Net $102.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $123.0M 105.7M $130.0M
YoY Change -5.41% 603.53% 584.46%
NET CHANGE
Cash From Operating Activities $5.603M -1.600M $4.059M
Cash From Investing Activities -$80.74M -127.4M -$75.90M
Cash From Financing Activities $123.0M 105.7M $130.0M
Net Change In Cash $47.89M -23.36M $58.21M
YoY Change -17.73% -81.99% 7.97%
FREE CASH FLOW
Cash From Operating Activities $5.603M -$1.600M $4.059M
Capital Expenditures $155.0K -$320.0K $184.0K
Free Cash Flow $5.448M -$1.280M $3.875M
YoY Change 40.59% -3.03% 390.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
102000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
781000 USD
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
122915000 USD
CY2021Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
130829000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
123017000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
130048000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47885000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58206000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
961000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1042000 USD
CY2022Q1 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
3309000 USD
CY2021Q1 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
8824000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94113000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46228000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47734000 USD
CY2021Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1370 pure
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105940000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15057000 USD
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
112690000 USD
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120157000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15074000 USD
CY2022Q1 uscb Time Deposits Less Than250000
TimeDepositsLessThan250000
104962000 USD
CY2021Q4 uscb Time Deposits Less Than250000
TimeDepositsLessThan250000
105819000 USD
CY2022Q1 uscb Advances Federal Home Loan Bank
AdvancesFederalHomeLoanBank
36000000 USD
CY2021Q4 uscb Advances Federal Home Loan Bank
AdvancesFederalHomeLoanBank
36000000 USD
CY2022Q1 uscb Accrued Interest And Other Liabilities
AccruedInterestAndOtherLiabilities
12478000 USD
CY2021Q4 uscb Accrued Interest And Other Liabilities
AccruedInterestAndOtherLiabilities
9478000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1775213000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1650042000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
310887000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
310666000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119391000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124245000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19458000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2516000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
192039000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
203897000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1967252000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1853939000 USD
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
12982000 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
11868000 USD
CY2022Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
2329000 USD
CY2021Q1 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
1844000 USD
CY2022Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
31000 USD
CY2021Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
16000 USD
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
15342000 USD
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
13728000 USD
CY2022Q1 uscb Interest Expense Interest Bearing Deposits
InterestExpenseInterestBearingDeposits
16000 USD
CY2021Q1 uscb Interest Expense Interest Bearing Deposits
InterestExpenseInterestBearingDeposits
14000 USD
CY2022Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
551000 USD
CY2021Q1 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
548000 USD
CY2022Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
259000 USD
CY2021Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
554000 USD
CY2022Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
137000 USD
CY2021Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
137000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
963000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
1253000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14379000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12475000 USD
CY2021Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
160000 USD
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14379000 USD
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
12635000 USD
CY2022Q1 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
900000 USD
CY2021Q1 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
889000 USD
CY2022Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
21000 USD
CY2021Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
62000 USD
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
334000 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
964000 USD
CY2022Q1 uscb Loan Settlement
LoanSettlement
161000 USD
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
529000 USD
CY2021Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
406000 USD
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
1945000 USD
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
2321000 USD
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5875000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5278000 USD
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
1270000 USD
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
1387000 USD
CY2022Q1 uscb Regulatory Assessment And Fees
RegulatoryAssessmentAndFees
213000 USD
CY2021Q1 uscb Regulatory Assessment And Fees
RegulatoryAssessmentAndFees
178000 USD
CY2022Q1 us-gaap Legal Fees
LegalFees
517000 USD
CY2021Q1 us-gaap Legal Fees
LegalFees
185000 USD
CY2022Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
387000 USD
CY2021Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
508000 USD
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1350000 USD
CY2021Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1141000 USD
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
9612000 USD
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
8677000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6712000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6279000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1858000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1498000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4854000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4781000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
781000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4854000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4854000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4781000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-22775000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-6070000 USD
CY2022Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax
65000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
21000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
62000 USD
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-5789000 USD
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-1503000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16942000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4629000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12088000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
152000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
203897000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4854000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16942000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
102000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
128000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
192039000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4781000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4629000 USD
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
781000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4854000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4781000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-160000 USD
CY2022Q1 uscb Depreciation And Amortization1
DepreciationAndAmortization1
188000 USD
CY2021Q1 uscb Depreciation And Amortization1
DepreciationAndAmortization1
329000 USD
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-169000 USD
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-54000 USD
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
807000 USD
CY2021Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
1249000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
128000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
53000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
21000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
62000 USD
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
334000 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
964000 USD
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
266000 USD
CY2021Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
170000 USD
CY2022Q1 uscb Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-1858000 USD
CY2021Q1 uscb Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-1498000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
328000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
462000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2838000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1660000 USD
CY2022Q1 uscb Increase Decrease In Accrued Interest And Other Liabilities
IncreaseDecreaseInAccruedInterestAndOtherLiabilities
3000000 USD
CY2021Q1 uscb Increase Decrease In Accrued Interest And Other Liabilities
IncreaseDecreaseInAccruedInterestAndOtherLiabilities
2071000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5603000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4059000 USD
CY2022Q1 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
2432000 USD
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
2626000 USD
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
42794000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
41094000 USD
CY2022Q1 uscb Proceeds From Maturities And Prepayments Of Available For Sale Securities
ProceedsFromMaturitiesAndPrepaymentsOfAvailableForSaleSecurities
14788000 USD
CY2021Q1 uscb Proceeds From Maturities And Prepayments Of Available For Sale Securities
ProceedsFromMaturitiesAndPrepaymentsOfAvailableForSaleSecurities
13699000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
14558000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
14248000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
617000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
72969000 USD
CY2022Q1 us-gaap Payments To Acquire Loans And Leases Held For Investment
PaymentsToAcquireLoansAndLeasesHeldForInvestment
70175000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
155000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
184000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
3643000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
9788000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
611000 USD
CY2022Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
177000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80735000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-75901000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
102000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
781000 USD
CY2022Q1 us-gaap Escrow Deposit
EscrowDeposit
30300000 USD
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
122915000 USD
CY2021Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
130829000 USD
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
28900000 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
14558000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
14248000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
158000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
75000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
123017000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
130048000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47885000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58206000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46228000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47734000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94113000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105940000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
961000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1042000 USD
CY2022Q1 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
3309000 USD
CY2021Q1 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
8824000 USD
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2515000 USD
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120157000 USD
CY2022Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax
65000 USD
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id="TextBlockContainer223" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:261px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2703" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Concentration of Credit Risks </div><div id="a2706" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:31px;">Credit<div style="display:inline-block;width:5px"> </div>risk<div style="display:inline-block;width:5px"> </div>represents<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>accounting<div style="display:inline-block;width:6px"> </div>loss<div style="display:inline-block;width:5px"> </div>that<div style="display:inline-block;width:5px"> </div>would<div style="display:inline-block;width:6px"> </div>be<div style="display:inline-block;width:5px"> </div>recognized<div style="display:inline-block;width:6px"> </div>at<div style="display:inline-block;width:5px"> </div>the<div style="display:inline-block;width:5px"> </div>reporting<div style="display:inline-block;width:6px"> </div>date<div style="display:inline-block;width:5px"> </div>if<div style="display:inline-block;width:5px"> </div>counterparties<div style="display:inline-block;width:6px"> </div>failed<div style="display:inline-block;width:5px"> </div>to </div><div id="a2707" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">perform as contracted and any collateral or security proved to be insufficient<div style="display:inline-block;width:5px"> </div>to cover the loss. Concentrations of credit risk </div><div id="a2709" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:61px;">(whether on or off-balance sheet) arising from financial instruments exist in relation to certain<div style="display:inline-block;width:2px"> </div>groups of customers. A group </div><div id="a2712" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:77px;">concentration arises when<div style="display:inline-block;width:6px"> </div>a number of<div style="display:inline-block;width:5px"> </div>counterparties have<div style="display:inline-block;width:5px"> </div>similar economic characteristics<div style="display:inline-block;width:6px"> </div>that would cause<div style="display:inline-block;width:5px"> </div>their ability </div><div id="a2714" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:92px;">to meet contractual obligations to be similarly affected by changes in economic or other conditions. The Company does not </div><div id="a2715" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:107px;">have a significant exposure to any individual customer<div style="display:inline-block;width:5px"> </div>or counterparty. </div><div id="a2719" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:138px;">At March<div style="display:inline-block;width:5px"> </div>31, 2022<div style="display:inline-block;width:6px"> </div>and<div style="display:inline-block;width:5px"> </div>December 31,<div style="display:inline-block;width:5px"> </div>2021, the<div style="display:inline-block;width:6px"> </div>Company<div style="display:inline-block;width:5px"> </div>had<div style="display:inline-block;width:5px"> </div>a concentration<div style="display:inline-block;width:7px"> </div>of risk<div style="display:inline-block;width:6px"> </div>with loans<div style="display:inline-block;width:6px"> </div>outstanding<div style="display:inline-block;width:5px"> </div>to the </div><div id="a2727" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:153px;">Company’s<div style="display:inline-block;width:7px"> </div>top<div style="display:inline-block;width:6px"> </div>ten<div style="display:inline-block;width:7px"> </div>lending<div style="display:inline-block;width:7px"> </div>relationships<div style="display:inline-block;width:7px"> </div>totaling<div style="display:inline-block;width:7px"> </div>$</div><div id="a2727_50_5" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:153px;">187.1</div><div id="a2727_55_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:349px;top:153px;"><div style="display:inline-block;width:6px"> </div>million<div style="display:inline-block;width:7px"> </div>and<div style="display:inline-block;width:7px"> </div>$</div><div id="a2727_69_5" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:153px;">156.4</div><div id="a2727_74_44" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:470px;top:153px;"><div style="display:inline-block;width:7px"> </div>million,<div style="display:inline-block;width:7px"> </div>respectively,<div style="display:inline-block;width:8px"> </div>at<div style="display:inline-block;width:7px"> </div>such<div style="display:inline-block;width:7px"> </div>dates.<div style="display:inline-block;width:7px"> </div>This </div><div id="a2748" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">concentration accounted for </div><div id="a2748_28_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:173px;top:169px;">14.9</div><div id="a2748_32_49" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:169px;">% of net loans outstanding at March 31, 2022 and </div><div id="a2748_81_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:169px;">13.1</div><div id="a2748_85_24" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:523px;top:169px;">% at December 31, 2021. </div><div id="a2772" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:199px;">At March 31, 2022 and December 31, 2021, the<div style="display:inline-block;width:2px"> </div>Company also had a concentration of credit<div style="display:inline-block;width:2px"> </div>risk with loans outstanding </div><div id="a2781" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:215px;">to foreign banks in Ecuador, Honduras, and El<div style="display:inline-block;width:2px"> </div>Salvador totaling $</div><div id="a2781_65_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:215px;">61.4</div><div id="a2781_69_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:215px;"><div style="display:inline-block;width:4px"> </div>million and $</div><div id="a2781_83_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:215px;">47.9</div><div id="a2781_87_39" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:517px;top:215px;"><div style="display:inline-block;width:3px"> </div>million, respectively, at such dates. </div><div id="a2791" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:230px;">These foreign banks maintained deposits<div style="display:inline-block;width:5px"> </div>with right of offset totaling<div style="display:inline-block;width:5px"> </div>$</div><div id="a2791_71_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:230px;">30.3</div><div id="a2791_75_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:230px;"><div style="display:inline-block;width:4px"> </div>million and $</div><div id="a2791_89_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:520px;top:230px;">28.9</div><div id="a2791_93_31" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:230px;"><div style="display:inline-block;width:4px"> </div>million at March 31, 2022 and </div><div id="a2809" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:245px;">December 31, 2021, respectively. </div></div><div id="TextBlockContainer227" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:63px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2841" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:15px;">At various times during<div style="display:inline-block;width:5px"> </div>the year,<div style="display:inline-block;width:5px"> </div>the Company has maintained<div style="display:inline-block;width:5px"> </div>deposits with other<div style="display:inline-block;width:5px"> </div>financial institutions. The exposure </div><div id="a2842" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:31px;">to the Company from<div style="display:inline-block;width:2px"> </div>these transactions is solely<div style="display:inline-block;width:2px"> </div>dependent upon daily balances<div style="display:inline-block;width:2px"> </div>and the financial strength<div style="display:inline-block;width:2px"> </div>of the respective </div><div id="a2844" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">institutions.</div></div>
CY2022Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
42000000.0 USD
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div id="TextBlockContainer231" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:63px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2890" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Reclassifications </div><div id="a2893" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:31px;">Certain<div style="display:inline-block;width:9px"> </div>amounts<div style="display:inline-block;width:9px"> </div>in<div style="display:inline-block;width:8px"> </div>the<div style="display:inline-block;width:9px"> </div>Consolidated<div style="display:inline-block;width:9px"> </div>Financial<div style="display:inline-block;width:9px"> </div>Statements<div style="display:inline-block;width:9px"> </div>have<div style="display:inline-block;width:9px"> </div>been<div style="display:inline-block;width:9px"> </div>reclassified<div style="display:inline-block;width:9px"> </div>to<div style="display:inline-block;width:8px"> </div>conform<div style="display:inline-block;width:9px"> </div>to<div style="display:inline-block;width:9px"> </div>the<div style="display:inline-block;width:9px"> </div>current </div><div id="a2900" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">presentation. Reclassifications had no impact on the net income<div style="display:inline-block;width:5px"> </div>or stockholders’ equity of the Company.</div></div>
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
419190000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
602000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
27578000 USD
CY2022Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
122361000 USD
CY2022Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
9671000 USD
CY2022Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
112690000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
405853000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2982000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7293000 USD
CY2021Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
122658000 USD
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
14000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
137000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
13000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
21000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
62000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1995000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2014000 USD
CY2022Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
2007000 USD
CY2022Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
2003000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
10518000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
10509000 USD
CY2022Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
11242000 USD
CY2022Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
10521000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
29019000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
29131000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
25144000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
22114000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
419190000 USD
CY2022Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
112690000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
303364000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
20821000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
137679000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
15525000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
441043000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
36346000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
311459000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5381000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
110794000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4095000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
422253000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9476000 USD
CY2022Q1 us-gaap Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
20000000.0 USD
CY2022Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1258971000 USD
CY2022Q1 uscb Percent Of Total Loans
PercentOfTotalLoans
1.000 pure
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1191659000 USD
CY2021Q4 uscb Percent Of Total Loans
PercentOfTotalLoans
1.000 pure
CY2022Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
583000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1578000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1258388000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1190081000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15074000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15057000 USD
CY2022Q1 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
171400000 USD
CY2021Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
185100000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15057000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
38000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
21000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15074000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15086000 USD
CY2021Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
160000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
92000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
9000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15009000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
335000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
14739000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15074000 USD
CY2022Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
8309000 USD
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1250662000 USD
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1258971000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
360000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
14697000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15057000 USD
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
10067000 USD
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1181592000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1191659000 USD
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1258971000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1191659000 USD
CY2022Q1 uscb Financing Receivable Including90 Days Or More Past Due Still Accruing And Excluding Non Accrual Before Allowance For Credit Loss
FinancingReceivableIncluding90DaysOrMorePastDueStillAccruingAndExcludingNonAccrualBeforeAllowanceForCreditLoss
1258971000 USD
CY2022Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
1258971000 USD
CY2021Q4 uscb Financing Receivable Including90 Days Or More Past Due Still Accruing And Excluding Non Accrual Before Allowance For Credit Loss
FinancingReceivableIncluding90DaysOrMorePastDueStillAccruingAndExcludingNonAccrualBeforeAllowanceForCreditLoss
1190469000 USD
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1190000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1191659000 USD
CY2022Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 USD
CY2021Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 USD
CY2022Q1 us-gaap Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
0 USD
CY2021Q1 us-gaap Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
7000 USD
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
3810000 USD
CY2022Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
3804000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
5717000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
5730000 USD
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
4499000 USD
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
4464000 USD
CY2022Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
335000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
4350000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
4315000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
360000 USD
CY2022Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8309000 USD
CY2022Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
8268000 USD
CY2022Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
335000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
10067000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
10045000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
360000 USD
CY2022Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
9187000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
10694000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
91000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
109000 USD
CY2022Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
8309000 USD
CY2021Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
8876000 USD
CY2022Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
335000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
360000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0 USD
CY2021Q4 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0 USD
CY2022Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1442000 USD
CY2021Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1235000 USD
CY2022Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
416000 USD
CY2021Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
263000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1858000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1498000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1858000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1498000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1409000 USD
CY2021Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1319000 USD
CY2022Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
289000 USD
CY2021Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
220000 USD
CY2022Q1 uscb Effective Income Tax Rate Reconciliation Bank Owned Life Insurance
EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance
67000 USD
CY2021Q1 uscb Effective Income Tax Rate Reconciliation Bank Owned Life Insurance
EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance
42000 USD
CY2022Q1 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
227000 USD
CY2021Q1 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
1000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1858000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1498000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
34929000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2022Q1 uscb Tieronecommonequityrequiredforcapitaladequacy
Tieronecommonequityrequiredforcapitaladequacy
60426000 USD
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27731000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28819000 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
3820000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
3816000 USD
CY2022Q1 uscb Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3407000 USD
CY2021Q4 uscb Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3595000 USD
CY2022Q1 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
6606000 USD
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
817000 USD
CY2022Q1 uscb Deferred Tax Assets Deferred Loan Fees
DeferredTaxAssetsDeferredLoanFees
148000 USD
CY2021Q4 uscb Deferred Tax Assets Deferred Loan Fees
DeferredTaxAssetsDeferredLoanFees
400000 USD
CY2022Q1 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
106000 USD
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
361000 USD
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
264000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
241000 USD
CY2022Q1 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
195000 USD
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
600000 USD
CY2022Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
142000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2000 USD
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
42419000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38651000 USD
CY2022Q1 uscb Deferred Tax Liability Lease Right Of Use Asset
DeferredTaxLiabilityLeaseRightOfUseAsset
3407000 USD
CY2021Q4 uscb Deferred Tax Liability Lease Right Of Use Asset
DeferredTaxLiabilityLeaseRightOfUseAsset
3595000 USD
CY2022Q1 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
152000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
127000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3559000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3722000 USD
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
38860000 USD
CY2021Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
75094000 USD
CY2021Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0600 pure
CY2021Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
100125000 USD
CY2022Q1 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0600 pure
CY2021Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800 pure
CY2021Q4 uscb Tier One Common Equity
TierOneCommonEquity
171484000 USD
CY2022Q1 uscb Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
0.0450 pure
CY2022Q1 uscb Tieronecommonequityrequiredtobewellcapitalized
Tieronecommonequityrequiredtobewellcapitalized
87282000 USD
CY2021Q4 uscb Excesstieronecommonequitytoriskweightedassets
Excesstieronecommonequitytoriskweightedassets
0.1370 pure
CY2021Q4 uscb Tieronecommonequityrequiredforcapitaladequacy
Tieronecommonequityrequiredforcapitaladequacy
56321000 USD
CY2022Q1 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
107425000 USD
CY2021Q4 uscb Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
0.0450 pure
CY2021Q4 uscb Tieronecommonequityrequiredtobewellcapitalized
Tieronecommonequityrequiredtobewellcapitalized
81352000 USD
CY2022Q1 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800 pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
959667 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.87
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.12
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.35
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
960667 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.90
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
322667 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.08
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1693000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
339667 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.37
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
64000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.91
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
403667 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.29
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
243666 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.73
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
208000 USD
CY2022Q1 uscb Tier One Common Equity
TierOneCommonEquity
179243000 USD
CY2022Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
131036000 USD
CY2021Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
141297000 USD
CY2022Q1 uscb Excesstieronecommonequitytoriskweightedassets
Excesstieronecommonequitytoriskweightedassets
0.1335 pure
CY2022Q1 uscb Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
0.0650 pure
CY2021Q4 uscb Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
0.0650 pure
CY2021Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
171484000 USD
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
781000 USD
CY2022Q1 uscb Percent Used To Calculate Income Allocation
PercentUsedToCalculateIncomeAllocation
0.20 pure
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4854000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4781000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
781000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4854000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4000000 USD
CY2022Q1 us-gaap Banking Regulation Capital Conservation Buffer Capital Conserved Minimum
BankingRegulationCapitalConservationBufferCapitalConservedMinimum
0.025 pure
CY2022Q1 us-gaap Capital
Capital
194564000 USD
CY2022Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1449 pure
CY2022Q1 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
107425000 USD
CY2022Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0800 pure
CY2022Q1 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
134281000 USD
CY2022Q1 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000 pure
CY2022Q1 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
179243000 USD
CY2022Q1 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1335 pure
CY2022Q1 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
80568000 USD
CY2022Q1 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
179243000 USD
CY2022Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0947 pure
CY2022Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
75681000 USD
CY2022Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.0400 pure
CY2022Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
94601000 USD
CY2022Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500 pure
CY2021Q4 us-gaap Capital
Capital
186735000 USD
CY2021Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1492 pure
CY2021Q4 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
100125000 USD
CY2021Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0800 pure
CY2021Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
125157000 USD
CY2021Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000 pure
CY2021Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
171484000 USD
CY2021Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0955 pure
CY2021Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
71825000 USD
CY2021Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.0400 pure
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
89781000 USD
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500 pure

Files In Submission

Name View Source Status
0001901637-22-000004-index-headers.html Edgar Link pending
0001901637-22-000004-index.html Edgar Link pending
0001901637-22-000004.txt Edgar Link pending
0001901637-22-000004-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uscb-10K-20211231.htm Edgar Link pending
uscb-10K-20211231p1i0.jpg Edgar Link pending
uscb-10K-20211231_htm.xml Edgar Link completed
uscb-20220331.xsd Edgar Link pending
uscb-20220331_cal.xml Edgar Link unprocessable
uscb-20220331_def.xml Edgar Link unprocessable
uscb-20220331_lab.xml Edgar Link unprocessable
uscb-20220331_pre.xml Edgar Link unprocessable